Yunliang Wang

发表

Novel cellular therapies for hepatobiliary malignancies.

N. Zhang, Haifeng Zhao, Yan-Yu Wang, 2022, Hepatobiliary & pancreatic diseases international : HBPD INT.

Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study

Haifeng Zhao, Jian Zhou, Yuan Ji, 2023, BMC Cancer.

High incidence combination of multiple primary malignant tumors of the digestive system

Haifeng Zhao, Xiao-bo Yang, Dan Liu, 2022, World journal of gastroenterology.

Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study

Haifeng Zhao, M. Zeng, Jia Fan, 2022, Liver Cancer.